All the Wall Street firms that we cover here at 24/7 Wall St. keep a list for their institutional and retail clients of high-conviction stock picks. These are generally the companies they not only like on a longer-term basis, but those that usually have big upside to the assigned target price. Since the start of the second half of the year, many firms on Wall Street have tweaked their lists to account for potential changes in 2020.
In a recent Raymond James research note, the analysts made a big contrarian move by adding an ultra-low-cost air carrier to the firm’s well-respected Analyst Current Favorites list of stocks to Buy.
Here we cover this new addition, and we also screened the list for other companies that are in sectors that have struggled some but could have big second-half upside potential. It is important to remember that no single analyst report should be used as a sole basis for any buying or selling decision.
This low cost carrier flies to many cities, and it is the newest addition to the Analyst Current Favorites list. Allegiant Travel Co. (NASDAQ: ALGT) has a unique business strategy: flying where other airlines do not. It connects 136 city pairs and typically flies each leisure route only a few times a week, using older planes with low capital costs. An early unbundler, the company generates more fees per passenger than any U.S. airline. Its largest market is Las Vegas, followed by Orlando and Phoenix.
The company announced earlier this year the largest service expansion in its history, which includes 44 new nonstop routes, including 14 routes to three new cities: Chicago, Boston and Houston. This major addition to service is driven by Allegiant’s goal of connecting leisure travelers in underserved cities to popular destinations around the country. Most of the 44 new routes are non-competitive, with no other airline providing service between those airports.
The Raymond James price target for the shares is $135, while the consensus target across Wall Street is $112.78. Allegiant Travel stock was last seen trading at $110.29, up over 8% on Friday.
This is a solid value buy in the health care sector. Cigna Corp. (NYSE: CI) is a major health services organization that provides insurance and related products and services in the United States and internationally. All products and services are provided exclusively by or through operating subsidiaries of Cigna, including Cigna Health and Life Insurance Company, Life Insurance Company of North America, Cigna Life Insurance Company of Canada and their affiliates.
The health care giant offers an integrated suite of health services, such as medical, dental, behavioral health, pharmacy, vision, supplemental benefits and other related products, including group life, accident and disability insurance. Cigna maintains sales capability in 30 countries and jurisdictions, and it has approximately 86 million customer relationships throughout the world.
Cigna has a partnership relationship with (and an equity stake in) MDLive for telehealth. Increased telehealth adoption should also translate to a shift in prescription fulfillment to nonphysical pharmacy locations, which should benefit the company’s Express Scripts business, which operates the largest mail pharmacy in the United States.
Raymond James has price target of $240, a bit below the consensus figure of $243.76. Friday’s last trade for Cigna Stock was reported at $175.54.
Source: Read Full Article